Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Sibur to IPO in the coming months

12/5/24 SIBR

Finance Ministry does not expect Gazprom dividends in 2025

12/4/24 GAZP

Shareholders of Henderson approved dividends for 9 months 2024

12/4/24 HNFG

Shareholders of Henderson approved dividends for 2023

12/4/24 HNFG

VK Video platform launched an updated web version on a separate domain

12/4/24 VKCO

Softline has entered the Indonesian market

12/4/24 SOFL

Kuibyshevazot bought out Tecnimont's stake in JV Volgafert

12/4/24 KAZT

Moscow Exchange summarized the results of trading in November

12/3/24 MOEX

MGKL acquired 26 pawnshops and commission stores

12/3/24 MGKL

Softline will merge three subsidiaries into a subholding

12/3/24 SOFL